HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Nambozi Selected Research

Malaria

1/2020Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
1/2020Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
3/2019Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study.
1/2017Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.
12/2016The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia.
3/2016Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
1/2016A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
1/2016Four artemisinin-based treatments in African pregnant women with malaria.
3/2015The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
2/2015Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Nambozi Research Topics

Disease

15Malaria
01/2020 - 11/2009
7Falciparum Malaria (Plasmodium falciparum Malaria)
01/2020 - 02/2011
3Infections
01/2020 - 02/2015
2Nausea
03/2016 - 01/2016
2Vomiting
03/2016 - 01/2016
2Asthenia
03/2016 - 01/2016
2Dizziness (Lightheadedness)
03/2016 - 01/2016
1Stillbirth
01/2020
1Birth Weight (Birth Weights)
01/2020
1Premature Birth (Birth, Premature)
01/2020
1Reinfection
03/2015

Drug/Important Bio-Agent (IBA)

10artemisinin (artemisinine)IBA
01/2020 - 11/2009
9Lumefantrine Drug Combination Artemether (Coartem)FDA Link
01/2020 - 11/2009
7piperaquineIBA
03/2019 - 11/2009
7artenimol (dihydroartemisinin)IBA
03/2019 - 11/2009
6ArtesunateIBA
03/2019 - 01/2015
5Mefloquine (Lariam)FDA LinkGeneric
03/2019 - 01/2015
4artesunate drug combination amodiaquineIBA
03/2019 - 01/2015
3Antimalarials (Antimalarial Agents)IBA
01/2020 - 03/2015
2Quinine (Quinson)FDA Link
01/2020 - 01/2020
2ArtemisininsIBA
01/2017 - 01/2016
2pyrimethamine drug combination fanasil (Fansidar)FDA Link
02/2015 - 06/2014
1hemozoinIBA
01/2020
1Chloroquine (Aralen)FDA LinkGeneric
12/2016
1Amodiaquine (Camoquin)FDA Link
03/2015

Therapy/Procedure

5Therapeutics
03/2019 - 11/2009
1Aftercare (After-Treatment)
03/2015
1Mosquito Nets
02/2015